IONS - Ionis Pharmaceuticals Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - In Vitro & In Vivo Diagnostic Substances - IONS (874015)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
75 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S57+0-1-8-16

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2017-11-16
IONSHougen Elizabeth LSVP, Finance, CFOS - Sale+OE$54.35-7,00010,392-40%-$380,450
D
2017-11-15
IONSKlein Joseph IIIDirS - Sale+OE$53.56-2,25010,039-18%-$120,510
2017-11-13
IONSKlein Joseph IIIDirS - Sale$55.39-3,0007,227-29%-$166,170
D
2017-11-01
IONSO'Neil Patrick R.SVP, Legal, GCS - Sale+OE$58.35-1,00010,433-9%-$58,350
D
2017-10-18
IONSBennett C FrankSVP, Antisense ResearchS - Sale+OE$65.00-12,25015,041-45%-$796,250
D
2017-10-18
IONSParshall B LynneCOOS - Sale+OE$65.00-16,11825,741-39%-$1,047,670
D
2017-10-13
IONSCrooke Stanley TCOB, CEOS - Sale+OE$59.46-16,500766,467-2%-$981,090
D
2017-10-13
IONSGeary Richard SSVP, DevelopmentS - Sale+OE$60.00-8,26812,351-40%-$496,080
D
2017-10-05
IONSO'Neil Patrick R.SVP, Legal, GCS - Sale+OE$55.00-1,00010,433-9%-$55,000
DM
2017-10-02
IONSCrooke Stanley TCOB, CEOS - Sale+OE$52.89-27,500766,467-3%-$1,454,475
DM
2017-09-05
IONSO'Neil Patrick R.SVP, Legal, GCS - Sale+OE$55.00-1,00010,433-9%-$55,000
D
2017-07-24
IONSBennett C FrankSVP, Antisense ResearchS - Sale+OE$59.29-10,00015,041-40%-$592,900
D
2017-07-20
IONSCrooke Stanley TCOB, CEOS - Sale+OE$55.35-11,000766,467-1%-$608,850
D
2017-07-17
IONSCrooke Stanley TCOB, CEOS - Sale+OE$52.45-16,500766,467-2%-$865,425
2017-07-03
IONSMonia Brett PSVP, Antisense Drug DiscoveryS - Sale$51.35-30911,626-3%-$15,867
D
2017-07-03
IONSCrooke Stanley TCOB, CEOS - Sale+OE$52.10-16,500766,467-2%-$859,688
D
2017-05-31
IONSMuto Frederick TDirS - Sale+OE$45.22-12,5006,158-67%-$565,250
D
2017-06-01
IONSO'Neil Patrick R.SVP, Legal, GCS - Sale+OE$48.00-7010,299-1%-$3,360
D
2017-05-01
IONSO'Neil Patrick R.SVP, Legal, GCS - Sale+OE$48.75-65010,299-6%-$31,6880-2
D
2017-04-25
IONSCrooke Stanley TCOB, CEOS - Sale+OE$47.81-16,500766,467-2%-$788,865+1+1
D
2017-04-24
IONSO'Neil Patrick R.SVP, Legal, GCS - Sale+OE$45.00-50010,449-5%-$22,500+1+1
D
2017-04-19
IONSCrooke Stanley TCOB, CEOS - Sale+OE$43.25-5,500766,467-1%-$237,875+3+8
2017-04-12
IONSO'Neil Patrick R.SVP, Legal, GCS - Sale$40.07-1,00010,449-9%-$40,0700+2+12
DM
2017-04-12
IONSCrooke Stanley TCOB, CEOS - Sale+OE$40.69-22,000766,467-3%-$895,0700+2+12
D
2017-03-03
IONSBennett C FrankSVP, Antisense ResearchS - Sale+OE$55.00-5,00014,788-25%-$275,000-7-15-21
D
2017-03-02
IONSCrooke Stanley TCOB, CEOS - Sale+OE$51.05-12,100766,467-2%-$617,705-7-15-21
D
2017-03-01
IONSParshall B LynneCOOS - Sale+OE$49.26-4,62525,651-15%-$227,828+2-13-27
D
2017-03-01
IONSO'Neil Patrick R.SVP, Legal, GCS - Sale+OE$49.29-1,50011,449-12%-$73,935+2-13-27
D
2017-02-06
IONSO'Neil Patrick R.SVP, Legal, GCS - Sale+OE$46.17-1,50012,449-11%-$69,254+2+4+1
D
2017-01-17
IONSBoyce SarahChief Business OfficerS - Sale+OE$46.29-1,3615,252-21%-$63,001-1-100
D
2017-01-17
IONSMonia Brett PSVP, Antisense Drug DiscoveryS - Sale+OE$46.29-2,50211,772-18%-$115,819-1-100
D
2017-01-17
IONSO'Neil Patrick R.SVP, Legal, GCS - Sale+OE$46.29-2,24613,449-14%-$103,968-1-100
D
2017-01-17
IONSBennett C FrankSVP, Antisense ResearchS - Sale+OE$46.29-2,42114,788-14%-$112,069-1-100
D
2017-01-17
IONSCrooke Stanley TCOB, CEOS - Sale+OE$46.29-15,957766,467-2%-$738,643-1-100
D
2017-01-17
IONSParshall B LynneCOOS - Sale+OE$46.29-7,24625,651-22%-$335,414-1-100
D
2017-01-17
IONSHougen Elizabeth LSVP, Finance, CFOS - Sale+OE$46.29-2,27310,288-18%-$105,218-1-100
D
2017-01-17
IONSGeary Richard SSVP, DevelopmentS - Sale+OE$46.29-2,44112,962-16%-$112,996-1-100
D
2017-01-10
IONSCrooke Stanley TCOB, CEOS - Sale+OE$49.25-13,200752,590-2%-$650,100-3-6-8
DM
2017-01-03
IONSCrooke Stanley TCOB, CEOS - Sale+OE$48.89-18,700752,590-2%-$914,320-5+2-10
D
2017-01-03
IONSMonia Brett PSVP, Antisense Drug DiscoveryS - Sale+OE$48.60-3097,872-4%-$15,017-5+2-10
2016-12-20
IONSMonia Brett PSVP, Antisense Drug DiscoveryS - Sale$52.48-1307,872-2%-$6,822+1+7-10
D
2016-12-15
IONSParshall B LynneCOOS - Sale+OE$50.00-4,00016,693-19%-$200,0000+5-4
D
2016-12-05
IONSHougen Elizabeth LSVP, Finance, CFOS - Sale+OE$46.05-2,5006,548-28%-$115,125+1+1+4
D
2016-12-05
IONSO'Neil Patrick R.SVP, Legal, GCS - Sale+OE$45.00-3509,526-4%-$15,750+1+1+4
D
2016-12-01
IONSParshall B LynneCOOS - Sale+OE$42.23-12,50016,693-43%-$527,865+7+9+10
D
2016-11-14
IONSHougen Elizabeth LSVP, Finance, CFOS - Sale+OE$47.50-2,5006,548-28%-$118,750-5-9+3
D
2016-11-14
IONSO'Neil Patrick R.SVP, Legal, GCS - Sale+OE$45.00-1,0009,526-10%-$45,000+1-6-3
DM
2016-11-09
IONSHougen Elizabeth LSVP, Finance, CFOS - Sale+OE$39.74-5,0006,548-43%-$198,725+1-6-3
DM
2016-11-09
IONSCrooke Stanley TCOB, CEOS - Sale+OE$37.72-33,000752,590-4%-$1,244,866+1-6-3
D
2016-11-09
IONSBennett C FrankSVP, Antisense ResearchS - Sale+OE$37.56-22,80510,803-68%-$856,605+1-6-3
D
2016-11-07
IONSBennett C FrankSVP, Antisense ResearchS - Sale+OE$34.00-5,00010,803-32%-$170,000+7+32+27+22
D
2016-10-05
IONSCrooke Stanley TCOB, CEOS - Sale+OE$36.61-11,000752,590-1%-$402,7100-12-21+13
D
2016-09-27
IONSCrooke Stanley TCOB, CEOS - Sale+OE$36.02-22,000752,590-3%-$792,500+3+2-27+13
D
2016-09-21
IONSCrooke Stanley TCOB, CEOS - Sale+OE$35.50-22,000752,590-3%-$781,000-1+1-20+11
D
2016-09-01
IONSParshall B LynneCOOS - Sale+OE$29.88-12,50016,693-43%-$373,545+3+2+21+58
D
2016-05-31
IONSMuto Frederick TDirS - Sale+OE$22.31-12,5004,043-76%-$278,900-3-10-2+100
D
2016-04-06
IONSO'Neil Patrick R.SVP, Legal, GCS - Sale+OE$45.00-1,0009,124-10%-$45,000-2+3-14-12
D
2016-04-06
IONSCrooke Stanley TCOB, CEOS - Sale+OE$46.12-11,000752,590-1%-$507,375-2+3-14-12
D
2016-03-31
IONSCrooke Stanley TCOB, CEOS - Sale+OE$40.73-11,000752,590-1%-$448,085+3+10-12
D
2016-03-23
IONSO'Neil Patrick R.SVP, Legal, GCS - Sale+OE$45.40-1,0009,124-10%-$45,400-8-3+5-16
D
2016-01-19
IONSCrooke Stanley TCOB, CEOS - Sale+OE$41.46-13,401752,590-2%-$555,598+5+12-4-30
D
2016-01-19
IONSHougen Elizabeth LSVP, Finance, CFOS - Sale+OE$41.47-1,8996,331-23%-$78,742+5+12-4-30
D
2016-01-19
IONSO'Neil Patrick R.SVP, Legal, GCS - Sale+OE$41.46-1,8719,124-17%-$77,574+5+12-4-30
D
2016-01-19
IONSParshall B LynneCOO, SecretaryS - Sale+OE$41.46-5,19216,290-24%-$215,257+5+12-4-30
D
2016-01-19
IONSGeary Richard SSVP, DevelopmentS - Sale+OE$41.46-2,1628,354-21%-$89,634+5+12-4-30
D
2016-01-19
IONSMonia Brett PSVP, Antisense Drug DiscoveryS - Sale+OE$41.46-2,2087,693-22%-$91,541+5+12-4-30
D
2016-01-19
IONSBoyce SarahChief Business OfficerS - Sale+OE$41.46-8721,735-33%-$36,151+5+12-4-30
D
2016-01-19
IONSBennett C FrankSVP, Antisense ResearchS - Sale+OE$41.46-2,11010,590-17%-$87,474+5+12-4-30
D
2016-01-05
IONSCrooke Stanley TCOB, CEOS - Sale+OE$62.10-5,500741,330-1%-$341,550+3-20-34-52
D
2016-01-04
IONSParshall B LynneCOO, SecretaryS - Sale+OE$61.05-8098,215-9%-$49,389-1-8-42-60
D
2016-01-04
IONSO'Neil Patrick R.SVP, Legal, GCS - Sale+OE$61.10-1,0006,302-14%-$61,100-1-8-42-60
D
2016-01-04
IONSMonia Brett PSVP, Antisense Drug DiscoveryS - Sale+OE$61.00-1274,358-3%-$7,747-1-8-42-60
D
2016-01-04
IONSCrooke Stanley TCOB, CEOS - Sale+OE$61.05-11,000741,330-1%-$671,550-1-8-42-60
DM
2015-12-15
ISISBennett C FrankSVP, Antisense ResearchS - Sale+OE$57.41-7,9097,316-52%-$454,045-1
D
2015-12-01
ISISO'Neil Patrick R.SVP, Legal, GCS - Sale+OE$61.50-1,0006,259-14%-$61,500-4-3

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top